The DKMS John Hansen Research Grant supports innovative research in blood stem cell transplantation and cell therapy for hematologic diseases (including blood cancers), aimed at advancing outcomes in transplant/cell-based therapies.
Eligibility Criteria:
- Applicants conducting research in blood stem cell transplantation and/or cell therapy for hematologic diseases.
- Refer to the call for any career-stage or geographic requirements (varies by cycle).
Funding Details:
- Competitive research grant (award amount and duration are defined in the DKMS call materials).
- Intended for innovative, high-impact research in transplant/cell therapy.
Deadline:
- February 16, 2026 (11:59 PM CET).
Where to go for further information: